-
-
-
-
-
-
-
BioLineRx (BLRX) Reports In-Line Q2 EPS
-
-
-
-
-
-
-
Jones Trading Downgrades BioLineRx (BLRX) to Hold
-
-
-
-
-
-
-
BioLineRx (BLRX) Announces USPTO Allowance of New Composition of Matter Patent on Motixafortide
-
-
-
481,540 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


